Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma

European Journal of Clinical Investigation

Volumn 29, Issue 9, 1999, Pages 793-801

  Iurlaro, M ^a   Loverro, G ^a   Vacca, A ^a,b   Cormio, G ^a   Ribatti, O ^a   Minischetti, M ^a   Ria, R ^a   Bruno, M ^a   Selvaggi, L ^a  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

Author keywords

Angiogenesis; Endometrial carcinoma; Endothelial cell; Metalloproteinases; Tumour invasion; Tumour progression

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MAJOR CLINICAL STUDY; MICROVASCULATURE; MYOMETRIUM; PRIORITY JOURNAL; STROMA CELL; TUMOR BIOPSY; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA; COLLAGENASES; ENDOMETRIAL NEOPLASMS; ENDOPEPTIDASES; FEMALE; GELATINASES; HUMANS; IN SITU HYBRIDIZATION; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MIDDLE AGED; MYOMETRIUM; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER;

EID: 0032836038     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00532.x     Document Type: Article

References (39)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst, 1989;82:4-6.
2. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenetic switch during tumorigenesis. Cell, 1996;86;353-64.
3. Hamada J, Cavanaugh PG, Lotan O. Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. Br J Cancer, 1992;66:349-54.
4. Folkman J. Angiogenesis and breast cancer. J Clin Oncol, 1994;12:441-3.
5. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev, 1993;73:161-95.
6. Zetter BR. Angiogenesis and tumor metastasis. Annu Rev Med, 1998;49:407-24.
7. Jang YC, Arumugam S, Ferguson M, Gibran NS, Isik FF. Changes in matrix composition during the growth and regression of human hemangiomas, J Surg Res, 1998;80:9-15.
8. Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res, 1998;58:334-41.
9. Lichtenbeld HC, Barendsz-Janson AF, Van Essen H, Struijker Boudier H, Griffioen AW, Hillen HF. Angiogenic potential of malignant and non-malignant human breast tissues in an in vivo angiogenesis model, Int J Cancer, 1998;77:455-9.
10. Fontanini G, Vignati S, Boldrini L, Chine S, Silvestri V, Lucchi M, et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma, Clin Cancer Res, 1997;3:861-5.
11. Vacca A, Ribatti D, Roncali L, Lospalluti M, Serio G, Carrel S et al. Mclanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer, 1993;72:455-61.
12. Ray JM, Stetler-Stevenson WG. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J, 1994;7:2062-72.
13. Suzuki I, Iigo M, Ishikawa C, Kuhara T, Asamoto M, Kunimoto T et al. Inhibitory effects of oleic and docosahexaenoic acids on lung metastasis by coloncarcinoma-26 cells are associated with reduced matrix metalloproteinase-2 and -9 activities. Int J Cancer, 1997;73:607-12.
14. Talvensaari-Mattila A, Paakko P, Hoyhtya M, Blanco-Sequeiros G, Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 immunoreactive protein: a market of aggressiveness in breast carcinoma. Cancer, 1998;83:1153-62.
15. Abulafia O, Triest WE, Sherer DM, Hansen CC, Ghezzi F. Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma. Obstet Gynecol, 1995;86:479-85.
16. Wagatsuma S, Konno R, Sato S, Yajima A. Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. Cancer, 1998;82:520-30.
17. Inoue Y, Abe K, Obata K, Yoshioka T, Ohmura G, Doh K et al. Immunohistochemical studies on matrix metalloproteinase-9 (MMP-9) and type IV collagen in endometrial carcinoma, J Obstet Gynaecol Res, 1997;23:139-45.
18. FIGO news. Int J Gynecol Obstet, 1989;28:189-93.
19. Yamauchi N, Sakamoto A, Uozaki H, Iihara K, Machinami R. Immunohistochemical analysis of endometrial adenocarcinoma for bcl-2 and p-53 in relation to expression of sex steroid receptor and proliferative activity. Int J Gynecol Pathol, 1996;15:202-8.
20. Ribatti D, Nico B, Vacca A, Marzullo A, Calvi N, Roncali L et al. Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas? Br J Cancer, 1998;77:1900-6.
21. Elias H, Hyde DM. Stereological measurement of isotropic structures. In: Elias H, Hyde DM, editors. A Guide to Practical Stereology. Basel: Karger 1983:25-44.
22. Vacca A, Moretti S, Ribatti D, Pellegrino A, Pimpinelli N, Bianchi B et al. Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. Eur J Cancer, 1997;33:1685-92.
23. Huhtala P, Tuuttila A, Chow LT, Lohi J, Keski-Oja J, Tryggvason K. Complete structure of the human gene for 92-kilodalton type IV collagenase. Divergent regulation of expression for the 92- and 72- kDa enzyme genes in HT-1080 cells. J Biol Chem, 1991;266:16485-90.
24. Dobbs SP, Hewett PW, Johnson IR, Carmichael J, Murray JC. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepitelial neoplasia. Br J Cancer, 1997;76:1410-5.
25. Zhang J, Nie G, Jian W, Woolley DE, Salamonsen LA. Mast cell regulation of human endometrial matrix metalloproteinases: a mechanism underlying menstruation. Biol Reprod, 1998;59:693-703.
26. Norrby K, Whooley D. Role of mast cells in mitogenesis and angiogenesis in normal tissues and tumour tissues. Adv Biosci, 1993;89:71-136.
27. Blair RJ, Mengh H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest, 1997;99:2691-700.
28. Ribatti D, Vacca A, Nico B, Quondamatteo F, Ria R, Minischetti M et al. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer, 1999;79:451-5.
29. Hampton AL, Salamonsen LA. Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation, J Endocrinol, 1994;141:1-3.
30. Osteen KG, Rodgers WH, Gaire M, Hargrove JT, Gorstein F, Matrisian LM. Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci USA, 1994;91:10129-33.
31. Marbaix E, Kokorine I, Henriet P, Donnez J, Courtoy PJ, Eeckhout Y. The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation. Biochem J, 1995;305:1027-30.
32. Hampton AL, Butt AR, Riley SC, Salamonsen LA. Tissue inhibitors of metalloproteinases in endometrium of ovariectomized steroid-treated ewes and during the estrous cycle and early pregnancy. Biol Reprod, 1995;53:302-11.
33. Huang HY, Wen Y, Irwin JC, Kruessel JS, Soong YK, Polan ML. Cytokine-mediated regulation of 92-kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells. J Clin Endocrinol Metab, 1998;83:1721-9.
34. Lockwood CJ, Krikun G, Hausknecht VA, Papp C, Schatz F. Matrix metalloproreinase and matrix metalloproteinase inhibitor expression in endometriat stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal. Endocrinology, 1998;139:4607-13.
35. Salamonsen LA, Woolley DE. Matrix metalloproteinascs in normal menstruation. Human Reprod, 1996;11:S124-33.
36. Iozzo RV. Tumor stroma as a regulator of neoplastic behaviour. Lab Invest, 1995;73:157-60.
37. Ohtawi H. Stromal reaction in cancer tissue: pathophysio-logic significance of the expression of matrix-degrading enzymes in relation to mattrix turnover and immune/inflammatory reactions. Pathol Int, 1998;48:1-9.
38. Gasparini G, Presta M. Clinical studies with angiogenesis inhibitors: biological rationale and challenges for their evaluation. Ann Oncol, 1996;7:441-4.
39. Jones A, Harris AL. New developments in angiogenesis: a major mechanism for tumour growth and target for therapy. Cancer J Sci Am, 1998;4:209-17.